December 26, 2024
The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a new guide titled Advising People on Using 988 Versus 911: Practical Approaches for Healthcare Providers.
December 17, 2024
Join the Maternal Health Access Project (MHAP) for a free two-part virtual training on substance use disorders during pregnancy and postpartum. Continuing Education Units (CEUs) will be available at no cost.
December 16, 2024
MHD Education and Training has posted the 1st Quarter 2025 Provider Training Schedule. These live webinars can also be found on the Provider Training Calendar located on the Education and Training page.
December 9, 2024
Effective November 1, 2024, MO HealthNet enrolled providers (including Fee-For-Service (FFS) and Managed Care (MC) Health Plan providers) who provide obstetric care/services, primary care, and emergency care to MO HealthNet participants can begin utilizing the new
The Maternal Health Access Project is offering a free virtual training on anxiety disorders during pregnancy and postpartum.
Screening, Assessing, and Managing Perinatal Anxiety Disorders offers two sessions, described below.
Session A:
The Mo HealthNet Provider Communications Unit assists providers with eligibility and coverage verification, enrollment status, annual review dates, questions regarding proper claim filing, claims resolution and disposition, billing errors, verifying check amounts, and more.
Effective October 1, 2024, the manufacturers Ibsa Pharma Inc. and Yaral Pharma Inc have chosen to no longer be part of the Medicaid Drug Rebate Program (MDRP). Both Ibsa Pharma Inc. and Yaral Pharma Inc. manufacture levothyroxine products along with other agents. As a result, MO HealthNet will no longer be able to pay claims for these manufacturer's products for dates of service on and after October 1, 2024.
